Actinic Keratosis

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

EMA safety_alert · 2020-04-30
Risks of Picato for actinic keratosis outweigh benefits
The EMA states that the risks of Picato (ingenol mebate) for actinic keratosis outweigh the benefits and recommends restricting or withdrawi…